Aston University, School of Life and Health Sciences, Birmingham, UK.
BJOG. 2011 Nov;118(12):1528-31. doi: 10.1111/j.1471-0528.2011.03057.x. Epub 2011 Jul 27.
Menorrhagia, or heavy menstrual bleeding (HMB), is a common gynaecological condition. As the aim of treatment is to improve women's wellbeing and quality of life (QoL), it is necessary to have effective ways to measure this. This study investigated the reliability and validity of the menorrhagia multi-attribute scale (MMAS), a menorrhagia-specific QoL instrument. Participants (n = 431) completed the MMAS and a battery of other tests as part of the baseline assessment of the ECLIPSE (Effectiveness and Cost-effectiveness of Levonorgestrel-containing Intrauterine system in Primary care against Standard trEatment for menorrhagia) trial. Analyses of their responses suggest that the MMAS has good measurement properties and is therefore an appropriate condition-specific instrument to measure the outcome of treatment for HMB.
月经过多，即经量过多（HMB），是一种常见的妇科病症。由于治疗的目的在于改善女性的健康状况和生活质量（QoL），因此需要有有效的方法来衡量这一点。本研究旨在探究月经过多多属性量表（MMAS）的可靠性和有效性，该量表是一种专门针对月经过多的生活质量评估工具。作为 ECLIPSE 试验（含左炔诺孕酮宫内节育系统的初级保健对标准治疗的月经过多的有效性和成本效益）基线评估的一部分，参与者（n=431）完成了 MMAS 和一系列其他测试。对他们的反应进行的分析表明，MMAS 具有良好的测量特性，因此是一种合适的特定于病症的工具，可用于衡量 HMB 治疗的结果。
